ScholarIQanswers from OpenAlex & ORCID
Jaffer A. Ajani
ResearcherPublications, citations & collaboration network
Jaffer A. Ajani is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Jaffer A. Ajani have?
ScholarIQindexed works
Jaffer A. Ajani has 1,735 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Jaffer A. Ajani have?
ScholarIQcitation count
Jaffer A. Ajani has 111,754 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Jaffer A. Ajani?
ScholarIQh-index
Jaffer A. Ajani has an h-index of 152 in OpenAlex.
What is the i10-index of Jaffer A. Ajani?
ScholarIQi10-index
Jaffer A. Ajani has an i10-index of 731 in OpenAlex.
What is the ORCID of Jaffer A. Ajani?
ScholarIQorcid
The ORCID for Jaffer A. Ajani is on the source record.
What is the OpenAlex record for Jaffer A. Ajani?
ScholarIQopenalex
The OpenAlex for Jaffer A. Ajani is on the source record.
What are the most-cited papers on Jaffer A. Ajani?
ScholarIQmost cited works
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
H. Wilke, Kei Muro, Eric Van Cutsem, Sang-Cheul Oh, G. Bodoky, Yasuhiro Shimada, Shuichi Hironaka, Naotoshi Sugimoto, Oleg Lipatov, Tae‐You Kim, David Cunningham, Philippe Rougier, Yoshito Komatsu, Jaffer A. Ajani, Michael Emig, Roberto Carlesi, David Ferry, Kumari Chandrawansa, Jonathan D. Schwartz, Atsushi Ohtsu
Adjuvant Nivolumab in Resected Esophageal or Gastroesophageal Junction Cancer
Ronan J. Kelly, Jaffer A. Ajani, Jarosław Kużdżał, Thomas Zander, Eric Van Cutsem, Guillaume Piessen, Guillermo Méndez, Josephine Feliciano, Satoru Motoyama, Astrid Lièvre, Hope E. Uronis, Elena Elimova, Cecile Grootscholten, Karen Geboes, Syed Zafar, Stephanie Snow, Andrew H. Ko, Kynan Feeney, Michael Schenker, Piotr Kocoń, Jenny Zhang, Lili Zhu, Ming Lei, Prianka Singh, Kaoru Kondo, James M. Cleary, Markus Moehler
Chemotherapy Followed by Surgery Compared with Surgery Alone for Localized Esophageal Cancer
David P. Kelsen, Robert J. Ginsberg, Thomas F. Pajak, Daniel G. Sheahan, Leonard L. Gunderson, Joanne Mortimer, Norman Estes, Daniel G. Haller, Jaffer A. Ajani, Walter Kocha, Bruce D. Minsky, Jack A. Roth
Fluorouracil, Doxorubicin, and Streptozocin in the Treatment of Patients With Locally Advanced and Metastatic Pancreatic Endocrine Carcinomas
Maria A. Kouvaraki, Jaffer A. Ajani, Paulo M. Hoff, Robert A. Wolff, Douglas B. Evans, Richard D. Lozano, James C. Yao
ARID1A deficiency promotes mutability and potentiates therapeutic antitumor immunity unleashed by immune checkpoint blockade
Jianfeng Shen, Zhenlin Ju, Zhao Wei, Lulu Wang, Yang Peng, Zhongqi Ge, Zachary D. Nagel, Jun Zou, Chen Wang, Prabodh Kapoor, Xiangyi Ma, Ding Ma, Jiyong Liang, Shumei Song, Jinsong Liu, Leona D. Samson, Jaffer A. Ajani, Guo‐Min Li, Han Liang, Xuetong Shen, Gordon B. Mills, Guang Peng